3.9 Article

Dissection of the Interplay between Class I PI3Ks and Rac Signaling in Phagocytic Functions

期刊

THESCIENTIFICWORLDJOURNAL
卷 10, 期 -, 页码 1826-1839

出版社

HINDAWI LTD
DOI: 10.1100/tsw.2010.178

关键词

PI3K; Rac; innate immunity; chemotaxis; phagocytosis; oxidative burst

资金

  1. Fondation Leducq
  2. European Union
  3. Telethon
  4. Regione Piemonte
  5. University of Torino
  6. AIRC

向作者/读者索取更多资源

Phagocytes, like neutrophils and macrophages, are specialized cells evolved to clear infectious pathogens. This function resides at the core of innate immunity and requires a series of concerted events that lead first to migration to the infected tissue and then to the killing of the invading pathogens. Molecular mechanisms underlying these processes are starting to emerge and point to the interplay between two families of crucial proteins: the PI3K lipid kinases and the Rac GTPases. This review focuses on how these two protein families contribute to migration, phagocytosis, and reactive oxygen species production, as well as their epistatic and feedback relations that finely tune these crucial aspects of the immune response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Oncology

The Strategy of PIKing a Target: What Is AKTually Most Effective?

Carlotta Costa, Ana Bosch

CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy

Konstantinos V. Floros, Timothy L. Lochmann, Bin Hu, Carles Monterrubio, Mark T. Hughes, Jason D. Wells, Cristina Bernado Morales, Maninderjit S. Ghotra, Carlotta Costa, Andrew J. Souers, Sosipatros A. Boikos, Joel D. Leverson, Ming Tan, Violeta Serra, Jennifer E. Koblinski, Joaquin Arribas, Aleix Prat, Laia Pare, Todd W. Miller, Mikhail G. Dozmorov, Hisashi Harada, Brad E. Windle, Maurizio Scaltriti, Anthony C. Faber

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Neurosciences

Mechanisms underlying the cross-talk between heart and cancer

Mara Brancaccio, Flora Pirozzi, Emilio Hirsch, Alessandra Ghigo

JOURNAL OF PHYSIOLOGY-LONDON (2020)

Article Oncology

PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer

Carlotta Costa, Ye Wang, Amy Ly, Yasuyuki Hosono, Ellen Murchie, Charlotte S. Walmsley, Tiffany Huynh, Christopher Healy, Rachel Peterson, Shogo Yanase, Charles T. Jakubik, Laura E. Henderson, Leah J. Damon, Daria Timonina, Ioannis Sanidas, Christopher J. Pinto, Mari Mino-Kenudson, James R. Stone, Nicholas J. Dyson, Leif W. Ellisen, Aditya Bardia, Hiromichi Ebi, Cyril H. Benes, Jeffrey A. Engelman, Dejan Juric

CANCER DISCOVERY (2020)

Article Multidisciplinary Sciences

Converging TLR9 and PI3Kgamma signaling induces sterile inflammation and organ damage

Braulio Henrique Freire Lima, Pedro Elias Marques, Lindisley Ferreira Gomides, Matheus Silverio Mattos, Lucas Kraemer, Celso M. Queiroz-Junior, Mark Lennon, Emilio Hirsch, Remo Castro Russo, Gustavo Batista Menezes, Edith M. Hessel, Augustin Amour, Mauro Martins Teixeira

SCIENTIFIC REPORTS (2019)

Article Multidisciplinary Sciences

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms

Ye Wang, Morvarid Mohseni, Angelo Grauel, Javier Estrada Diez, Wei Guan, Simon Liang, Jiyoung Elizabeth Choi, Minying Pu, Dongshu Chen, Tyler Laszewski, Stephanie Schwartz, Jane Gu, Leandra Mansur, Tyler Burks, Lauren Brodeur, Roberto Velazquez, Steve Kovats, Bhavesh Pant, Giri Buruzula, Emily Deng, Julie T. Chen, Farid Sari-Sarraf, Christina Dornelas, Malini Varadarajan, Haiyan Yu, Chen Liu, Joanne Lim, Huai-Xiang Hao, Xiaomo Jiang, Anthony Malamas, Matthew J. LaMarche, Felipe Correa Geyer, Margaret McLaughlin, Carlotta Costa, Joel Wagner, David Ruddy, Pushpa Jayaraman, Nathaniel D. Kirkpatrick, Pu Zhang, Oleg Iartchouk, Kimberly Aardalen, Viviana Cremasco, Glenn Dranoff, Jeffrey A. Engelman, Serena Silver, Hongyun Wang, William D. Hastings, Silvia Goldoni

Summary: The study unveiled a new immune modulatory function of SHP2, with inhibition promoting anti-tumor immunity by enhancing T cell cytotoxicity and immune-mediated tumor regression. Additionally, SHP2 inhibition improved responses to anti-PD-1 blockade, suggesting its potential as a promising strategy for cancer immunotherapy.

SCIENTIFIC REPORTS (2021)

Review Oncology

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer

Huayi Li, Lorenzo Prever, Emilio Hirsch, Federico Gulluni

Summary: The PI3K signaling pathway is crucial in breast cancer and inhibitors targeting this pathway show promising activity, but resistance and adverse reactions limit their efficacy. Combination therapies and identifying suitable patient subpopulations are needed to enhance therapeutic benefit.

CANCERS (2021)

Article Biology

PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFβ1-Stimulated Cardiomyocytes

Paulin Brosinsky, Julia Bornbaum, Bjorn Warga, Lisa Schulz, Klaus-Dieter Schluter, Alessandra Ghigo, Emilio Hirsch, Rainer Schulz, Gerhild Euler, Jacqueline Heger

Summary: The study demonstrates the involvement of PI3K and ALK5/SMAD pathways in TGF beta(1)-induced cardiomyocyte apoptosis and impaired function, with a partial dependence on PI3K gamma.

BIOLOGY-BASEL (2021)

Review Biochemistry & Molecular Biology

PI3K Signaling in Mechanisms and Treatments of Pulmonary Fibrosis Following Sepsis and Acute Lung Injury

Jean Piero Margaria, Lucia Moretta, Jose Carlos Alves-Filho, Emilio Hirsch

Summary: This article summarizes the progress in understanding the role of PI3K/Akt in the development of lung fibrosis and its causative pathological context, including sepsis as well as acute lung injury (ALI) and its consequent acute respiratory distress syndrome (ARDS). Current knowledge about PI3K inhibitors for pulmonary fibrosis treatment, including drugs under development as well as in clinical trials, is further summarized. The discussion also includes how the design of inhaled compounds targeting the PI3K pathways might potentiate efficacy and improve tolerability.

BIOMEDICINES (2022)

Editorial Material Cardiac & Cardiovascular Systems

'Circulating' RNA-based therapies in Cardio-Oncology

Carlo G. Tocchetti, Alessandra Ghigo, Emilio Hirsch

Summary: This editorial discusses the study conducted by Lu et al. on the protective effect of circular RNA derived from the insulin receptor locus against doxorubicin-induced cardiotoxicity.

EUROPEAN HEART JOURNAL (2022)

Editorial Material Oncology

Prokineticin-izing Doxorubicin-Damaged Hearts

Emilio Hirsch

JACC: CARDIOONCOLOGY (2019)

Review Biochemistry & Molecular Biology

Class II PI3Ks at the Intersection between Signal Transduction and Membrane Trafficking

Jean Piero Margaria, Edoardo Ratto, Luca Gozzelino, Huayi Li, Emilio Hirsch

BIOMOLECULES (2019)

Article Oncology

NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263

Anahita Dastur, Ahyun Choi, Carlotta Costa, Xunqin Yin, August Williams, Joseph McClanaghan, Max Greenberg, Justine Roderick, Neha U. Patel, Jessica Boisvert, Ultan McDermott, Mathew J. Garnett, Jorge Almenara, Steven Grant, Kathryn Rizzo, Jeffrey A. Engelman, Michelle Kelliher, Anthony C. Faber, Cyril H. Benes

CLINICAL CANCER RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Functions of PDE3 Isoforms in Cardiac Muscle

Matthew Movsesian, Faiyaz Ahmad, Emilio Hirsch

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)

Article Oncology

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression

Timothy L. Lochmann, Konstantinos V. Floros, Mitra Naseri, Krista M. Powell, Wade Cook, Ryan J. March, Giovanna T. Stein, Patricia Greninger, Yuki Kato Maves, Laura R. Saunders, Scott J. Dylla, Carlotta Costa, Sosipatros A. Boikos, Joel D. Leverson, Andrew J. Souers, Geoffrey W. Krystal, Hisashi Harada, Cyril H. Benes, Anthony C. Faber

CLINICAL CANCER RESEARCH (2018)

暂无数据